Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Hatoon Ezzat, MBBS, FRCP, ABIM, R. Robert Schellenberg, Heather A Leitch, MD, PhD, FRCPC, Linda M Vickars, MD, FRCP(C)

Blood (2011) 118 (21): 5280.

https://doi.org/10.1182/blood.V118.21.5280.5280

Published: 2011

Journal Articles

Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study,

Jean-Philippe Galanaud, Susan R Kahn, MD, Michael Kovacs, Christina Holcroft, Marisol Betancourt, Philip S Wells, David Anderson, Isabelle Chagnon, MD, Gregoire Le Gal, MD, Susan Solymoss, MD, Mark A. Crowther, MD, FRCPC, Arnaud Perrier, Richard H. White, MD, Linda M Vickars, MD, FRCP(C), Tim Ramsay, Marc A. Rodger, MD, MSc

Blood (2011) 118 (21): 3332.

https://doi.org/10.1182/blood.V118.21.3332.3332

Published: 2011

Journal Articles

Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study

Jean-Philippe Galanaud, Susan R. Kahn, MD, MSc, Michael Kovacs, Christina Holcroft, Marisol Betancourt, Philip S Wells, David Anderson, Isabelle Chagnon, MD, Gregoire Le Gal, MD, PhD, Susan Solymoss, MD, Mark A. Crowther, MD, FRCPC, Arnaud Perrier, Richard H. White, MD, Linda M Vickars, MD, FRCP(C), Tim Ramsay, Marc Rodger, MD, FRCPC

Blood (2011) 118 (21): 1236.

https://doi.org/10.1182/blood.V118.21.1236.1236

Published: 2011

Journal Articles

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Heather A Leitch, MD, PhD, FRCPC, Christopher Chan, Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Linda M Vickars, MD, FRCP(C)

Blood (2011) 118 (21): 1732.

https://doi.org/10.1182/blood.V118.21.1732.1732

Published: 2011

Journal Articles

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

Kimberley LS Ambler, MD, FRCP(C), Linda M Vickars, MD, FRCP(C), Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Julio SG Montaner, MD, FRCPC, FCCP, Marianne Harris, MD, FRCPC, Heather A Leitch, MD, PhD, FRCP(C)

Blood (2010) 116 (21): 2522.

https://doi.org/10.1182/blood.V116.21.2522.2522

Published: 2010

NARROW

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study,

Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

Email alerts

ASH Publications

American Society of Hematology

Successful Tolerance of Deferasirox Following Desensitization for Significant Skin Rash

Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study,

Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only